• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嵌合H5流感病毒样颗粒疫苗在鸡体内引发的跨谱系抗体反应比在鸭体内更广泛。

Chimeric H5 influenza virus-like particle vaccine elicits broader cross-clade antibody responses in chickens than in ducks.

作者信息

Park Jaekeun, Song Chang-Seon, Chung David Hyunjung, Choi Sangyong, Kwon Junghoon, Youk Sungsu, Lee Dong-Hun

机构信息

College of Veterinary Medicine, Konkuk University, Seoul, South Korea.

Department of Veterinary Medicine, Virginia-Maryland College of Veterinary Medicine, University of Maryland, College Park, MD, United States.

出版信息

Front Vet Sci. 2023 Jun 15;10:1158233. doi: 10.3389/fvets.2023.1158233. eCollection 2023.

DOI:10.3389/fvets.2023.1158233
PMID:37396994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10310301/
Abstract

Eurasian-lineage highly pathogenic avian influenza (HPAI) H5 viruses have spread throughout Asia, the Middle East, Europe, Africa, and most recently, North and South America. These viruses are independently evolving into genetically and antigenically divergent clades, and broad-spectrum vaccines protecting against these divergent clades are needed. In this study, we developed a chimeric virus-like particle (VLP) vaccine co-expressing hemagglutinins from two clades (clades 1 and 2.3.2.1) of HPAI H5 viruses and performed comparative cross-clade hemagglutination inhibition (HI) analysis in chickens and ducks. The chimeric VLP immunization induced a significantly broader spectrum of antibodies against various clades of HPAI H5 viruses than monovalent VLPs both in chickens and ducks. While the chimeric VLP led to broadened antibody responses in both species, significantly lower levels of HI antibodies were elicited in ducks than in chickens. Moreover, boost immunization failed to increase antibody responses in ducks regardless of the VLPs used, in contrast to chickens that showed significantly enhanced antibody responses upon boost immunization. These results suggest (1) the potential application of the chimeric VLP technology in poultry to help control HPAI H5 viruses by offering broader antibody responses against antigenically different strains and (2) possible obstacles in generating high levels of antibody responses against HPAI H5 viruses in ducks via vaccination, implying the need for advanced vaccination strategies for ducks.

摘要

欧亚谱系高致病性禽流感(HPAI)H5病毒已蔓延至亚洲、中东、欧洲、非洲,最近还传播到了南北美洲。这些病毒正在独立演化为基因和抗原性不同的分支,因此需要能抵御这些不同分支的广谱疫苗。在本研究中,我们开发了一种嵌合病毒样颗粒(VLP)疫苗,该疫苗共表达来自HPAI H5病毒两个分支(分支1和2.3.2.1)的血凝素,并在鸡和鸭中进行了比较性跨分支血凝抑制(HI)分析。与单价VLP相比,嵌合VLP免疫在鸡和鸭中均诱导产生了针对HPAI H5病毒各分支的明显更广泛的抗体谱。虽然嵌合VLP在两种动物中均引发了更广泛的抗体反应,但鸭产生的HI抗体水平明显低于鸡。此外,与鸡在加强免疫后抗体反应显著增强相反,无论使用何种VLP,鸭的加强免疫均未能增加抗体反应。这些结果表明:(1)嵌合VLP技术在禽类中具有潜在应用价值,可通过提供针对抗原性不同毒株的更广泛抗体反应来帮助控制HPAI H5病毒;(2)通过疫苗接种在鸭中产生针对HPAI H5病毒的高水平抗体反应可能存在障碍,这意味着需要针对鸭的先进疫苗接种策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc31/10310301/0d5c63feb133/fvets-10-1158233-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc31/10310301/1d1a70c28060/fvets-10-1158233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc31/10310301/fe8dd09abff3/fvets-10-1158233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc31/10310301/81d4e30c0b82/fvets-10-1158233-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc31/10310301/34261f1f22f9/fvets-10-1158233-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc31/10310301/0d5c63feb133/fvets-10-1158233-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc31/10310301/1d1a70c28060/fvets-10-1158233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc31/10310301/fe8dd09abff3/fvets-10-1158233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc31/10310301/81d4e30c0b82/fvets-10-1158233-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc31/10310301/34261f1f22f9/fvets-10-1158233-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc31/10310301/0d5c63feb133/fvets-10-1158233-g005.jpg

相似文献

1
Chimeric H5 influenza virus-like particle vaccine elicits broader cross-clade antibody responses in chickens than in ducks.嵌合H5流感病毒样颗粒疫苗在鸡体内引发的跨谱系抗体反应比在鸭体内更广泛。
Front Vet Sci. 2023 Jun 15;10:1158233. doi: 10.3389/fvets.2023.1158233. eCollection 2023.
2
Vaccine optimization for highly pathogenic avian influenza: Assessment of antibody responses and protection for virus-like particle vaccines in chickens.高致病性禽流感疫苗优化:鸡体内病毒样颗粒疫苗的抗体反应及保护作用评估
Vaccine X. 2024 Sep 6;20:100552. doi: 10.1016/j.jvacx.2024.100552. eCollection 2024 Oct.
3
Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.用含有来自三个H5N1进化枝的H5抗原的病毒样颗粒进行疫苗接种可保护鸡免受H5N1和H5N8流感病毒的侵害。
Vaccine. 2016 Mar 18;34(13):1575-1581. doi: 10.1016/j.vaccine.2016.02.011. Epub 2016 Feb 8.
4
Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).一种重组火鸡疱疹病毒H5疫苗对家鸭(绿头鸭)抵抗H5N1进化分支1.1.2和2.3.2.1高致病性禽流感病毒攻击的效力
Avian Dis. 2016 Mar;60(1):22-32. doi: 10.1637/11282-091615-Reg.1.
5
Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.灭活嵌合血凝素H9/H5N2禽流感病毒的疫苗效力及其对标记疫苗策略的适用性
J Virol. 2017 Feb 28;91(6). doi: 10.1128/JVI.01693-16. Print 2017 Mar 15.
6
Protective efficacy of an inactivated chimeric H5 avian influenza vaccine against H5 highly pathogenic avian influenza virus clades 2.3.4.4 and 2.3.2.1.一种灭活嵌合 H5 禽流感疫苗对 H5 高致病性禽流感病毒 2.3.4.4 和 2.3.2.1 谱系的保护效力。
J Gen Virol. 2018 Dec;99(12):1600-1607. doi: 10.1099/jgv.0.001140. Epub 2018 Oct 25.
7
Rapid Construction and Immunogenicity Testing of a Novel H5 Virus-Like Particle Prototype Vaccine Against Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Virus.针对2.3.4.4分支H5N8高致病性禽流感病毒的新型H5病毒样颗粒原型疫苗的快速构建及免疫原性测试
Avian Dis. 2019 Mar 1;63(sp1):203-208. doi: 10.1637/11888-042718-Reg.1.
8
Protective efficacy of an inactivated chimeric H7/H5 avian influenza vaccine against highly pathogenic avian influenza H7N9 and clade 2.3.4.4 H5 viruses.一种灭活嵌合 H7/H5 禽流感疫苗对高致病性禽流感 H7N9 和 2.3.4.4 分支 H5 病毒的保护效力。
Vet Microbiol. 2018 Sep;223:21-26. doi: 10.1016/j.vetmic.2018.07.011. Epub 2018 Jul 17.
9
Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.计算优化的广泛反应性抗原(COBRA)血凝素插入的重组马立克氏病病毒载体疫苗对遗传多样的 H5 高致病性禽流感病毒的效力。
Vaccine. 2021 Apr 1;39(14):1933-1942. doi: 10.1016/j.vaccine.2021.02.075. Epub 2021 Mar 11.
10
A Rationally Designed H5 Hemagglutinin Subunit Vaccine Provides Broad-Spectrum Protection against Various H5Nx Highly Pathogenic Avian Influenza Viruses in Chickens.一种合理设计的H5血凝素亚单位疫苗为鸡提供了针对多种H5Nx高致病性禽流感病毒的广谱保护。
Vaccines (Basel). 2024 Aug 21;12(8):932. doi: 10.3390/vaccines12080932.

本文引用的文献

1
Single dose of multi-clade virus-like particle vaccine protects chickens against clade 2.3.2.1 and clade 2.3.4.4 highly pathogenic avian influenza viruses.单剂量多分支病毒样颗粒疫苗可保护鸡免受 2.3.2.1 分支和 2.3.4.4 高致病性禽流感病毒的侵害。
Sci Rep. 2021 Jul 2;11(1):13786. doi: 10.1038/s41598-021-93060-8.
2
Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.灭活 H5 疫苗种株对不同鸭/广东谱系 H5N1 高致病性禽流感病毒的交叉保护作用。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.00720-20.
3
Domestic ducks play a major role in the maintenance and spread of H5N8 highly pathogenic avian influenza viruses in South Korea.
国内鸭子在韩国 H5N8 高致病性禽流感病毒的维持和传播中发挥了重要作用。
Transbound Emerg Dis. 2020 Mar;67(2):844-851. doi: 10.1111/tbed.13406. Epub 2019 Nov 10.
4
Efficacy of Two Licensed Avian Influenza H5 Vaccines Against Challenge with a 2015 U.S. H5N2 clade 2.3.4.4 Highly Pathogenic Avian Influenza Virus in Domestic Ducks.两种获许可的禽流感H5疫苗针对2015年美国H5N2 2.3.4.4分支高致病性禽流感病毒对家鸭攻毒的效力
Avian Dis. 2019 Mar 1;63(1):90-96. doi: 10.1637/11895-050918-Reg.1.
5
Innate Immune Responses to Avian Influenza Viruses in Ducks and Chickens.鸭和鸡对禽流感病毒的天然免疫反应
Vet Sci. 2019 Jan 10;6(1):5. doi: 10.3390/vetsci6010005.
6
Evolution, global spread, and pathogenicity of highly pathogenic avian influenza H5Nx clade 2.3.4.4.高致病性禽流感H5Nx进化分支2.3.4.4的进化、全球传播及致病性
J Vet Sci. 2017 Aug 31;18(S1):269-280. doi: 10.4142/jvs.2017.18.S1.269.
7
Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.含有不同 H5 血凝素的同源和异源抗原匹配疫苗可提供不同程度的保护,使鸡免受 2014 年美国 H5N8 和 H5N2 2.3.4.4 高致病性禽流感病毒的侵害。
Vaccine. 2017 Nov 1;35(46):6345-6353. doi: 10.1016/j.vaccine.2017.04.042. Epub 2017 Apr 26.
8
Isolation and genetic characterization of a novel 2.2.1.2a H5N1 virus from a vaccinated meat-turkeys flock in Egypt.从埃及一群接种过疫苗的肉用火鸡中分离出一种新型2.2.1.2a H5N1病毒并进行基因特征分析。
Virol J. 2017 Mar 9;14(1):48. doi: 10.1186/s12985-017-0697-5.
9
Detection and Characterization of Clade 1 Reassortant H5N1 Viruses Isolated from Human Cases in Vietnam during 2013.2013年从越南人间病例中分离出的1型重配H5N1病毒的检测与特征分析
PLoS One. 2015 Aug 5;10(8):e0133867. doi: 10.1371/journal.pone.0133867. eCollection 2015.
10
Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014.2013 - 2014年期间甲型禽流感病毒2.1.3.2a、2.2.1和2.3.4进化分支导致的命名更新。
Influenza Other Respir Viruses. 2015 Sep;9(5):271-6. doi: 10.1111/irv.12324.